Table 2.

Lipoproteins stratified by baseline eGFR in the Chronic Renal Insufficiency Cohort study

LipoproteinOverall (n=3939)eGFR<30 ml/min per 1.73 m2 (n=806)eGFR 30 to <40 ml/min per 1.73 m2 (n=902)eGFR 40 to <50 ml/min per 1.73 m2 (n=859)eGFR 50 to <60 ml/min per 1.73 m2 (n=668)eGFR≥60 ml/min per 1.73 m2 (n=702)P Value
Total cholesterol (mg/dl) 183.7±45.6182.9±52.9182.6±44.5183.5±46.2183.2±43.0186.6±39.10.45
LDL cholesterol (mg/dl)102.7±35.699.1±38.9100.3±34.6102.3±36.2104.6±34.2108.6±32.4<0.001
HDL cholesterol (mg/dl)47.5±15.545.2±14.647.0±15.547.2±14.947.9±15.450.8±16.7<0.001
VLDL cholesterol (mg/dl)27 (17–42)31 (19–47)30 (19–43)29 (17–43)25 (15–39)22 (13–35)<0.001
Triglycerides (mg/dl)128.5 (89–186)139 (100–205)135 (94–196)133 (92–193)120 (84–177)109 (79–156)<0.001
Lp(a) (mg/dl)24.5 (9–59)31.3 (12–69)26.45 (9–63)23.35 (8–64)23 (8–53)18.3 (7–46)<0.001
ApoA-I 136.7±29.6132.4±28.7136.7±30.9136.2±29.3137.1±28.6141.6±29.4<0.001
ApoB84.2±24.685.1±28.083.8±24.083.9±24.683.9±23.584.5±22.30.82
  • Values expressed with a plus/minus sign are the mean±SD. Values expressed with ranges are the median (interquartile range). Lp(a), lipoprotein(a).